Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0761
D

Failure to Label Multi-Dose Insulin Pen with Open and Expiration Dates

Los Angeles, California Survey Completed on 11-17-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A multi-dose insulin pen used for a resident with diabetes was found to be unlabeled with the date it was opened and its expiration date. The resident, who had a history of diabetes mellitus and fluctuating capacity to make medical decisions, was admitted to the facility and had an order for Insulin Glargine. During an observation, a nurse confirmed that the insulin pen in use for this resident was not labeled as required. Multiple staff interviews confirmed that the pen should have been labeled with both the open and expiration dates, in accordance with facility policy and the manufacturer's instructions, which specify that the pen should not be used more than 28 days after opening. Further review of the facility's policy and the insulin manufacturer's guidelines confirmed the requirement for labeling multi-dose vials and pens with the date opened and expiration date. The Director of Nursing acknowledged that the facility's policy was not followed in this instance. The lack of labeling meant that staff could not determine when the insulin pen was first used or when it should be discarded, as confirmed by interviews with nursing staff and the pharmacist.

An unhandled error has occurred. Reload 🗙